| Organism name | Artemisia judaica |
|---|---|
| Genus | Artemisia |
| Family | Asteraceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Artemisia judaica |
|---|---|
| Linked NCBI taxonomy ID | 205369 |
| Linked level | species |
| Family in NCBI taxonomy | Asteraceae |
|---|---|
| ID | 4210 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | asterids |
|---|---|
| ID | 71274 |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00006383
|
Neoisoschaftoside
|
No. 1 | No. 15 |
|
||||
|
C00006382
|
Neoschaftoside
|
CHEMBL1537012
|
7 / 2 / 2 | No. 1 | No. 15 |
|
||
|
C00004338
|
Chrysoeriol 7-glucoside
/ Luteolin 3'-methyl ether-7-glucoside / Luteolin 3'-methyl ether 7-glucoside / 5,7,4'-Trihydroxy-3'-methoxyflavone 7-beta-D-glucopyranoside |
CHEMBL486391
|
No. 2 | No. 15 |
|
|||
|
C00004339
|
Chrysoeriol 7-O-glucuronide
/ 5,7,4'-Trihydroxy-3'-methoxyflavone / Luteolin 3'-methyl ether 7-glucuronide |
CHEMBL519735
|
No. 2 | No. 15 |
|
|||
|
C00013001
|
1-Epialkhanol
/ [3S-(3alpha,3aalpha,5abeta,6beta,8alpha,9bbeta)]- 3a,4,5,5a,6,7,8,9b-Octahydro-6,8-dihydroxy-3,5a,9-trimethylnaphtho[1,2-b]furan-2(3H)-one |
No. 528 |
|
|||||
|
C00012247
|
1alpha-Hydroxyisoafraglaucolide
/ [7S-(5Z,7R*,9R*,10E,11aS*)]-9-(acetyloxy)-3-[(acetyloxy)methyl]-7,8,9,11a-tetrahydro-7-hydroxy-6,10-dimethylcyclodeca[b]furan-2(4H)-one |
No. 637 |
|
|||||
|
C00012246
|
13-Desacetyl-1beta-hydroxyafraglaucolide
/ [7S-(5Z,7R*,9R*,10E,11aS*)]-9-(acetyloxy)-7,8,9,11a-tetrahydro-7-hydroxy-3-(hydroxymethyl)-6,10-dimethylcyclodeca[b]furan-2(4H)-one, |
No. 637 |
|
|||||
|
C00012248
|
13-Desacetyl-1alpha-hydroxyafraglaucolide
/ [7R-(7R*,9S*,10E,11aR*)]- 9-(Acetyloxy)-5,6,7,8,9,11a-hexahydro-7-hydroxy-3-(hydroxymethyl)-10-methyl-6-methylenecyclodeca[b]furan-2(4H)-one, |
No. 637 |
|
|||||
|
C00003393
|
Barrelin
/ Vulgarin / Tauremizin / Judaicin (sesquiterpene) |
CHEMBL1422618
|
5 / 14 / 40 | No. 755 | No. 38 |
|
||
|
C00013071
|
4alpha-Hydroperoxydesoxyvulgarin
/ [3S-(3alpha,3aalpha,5abeta,9alpha,9aalpha,9bbeta)]-3a,5,5a,9,9a,9b-Hexahydro-9-hydroperoxy-3,5a,9-trimethylnaphtho[1,2-b]furan-2,6(3H,4H)-dione |
No. 755 | No. 38 |
|
||||
|
C00013072
|
4-Epivulgarin
/ [3S-(3alpha,3aalpha,5abeta,9beta,9aalpha,9bbeta)]-3a,5,5a,9,9a,9b-Hexahydro-9-hydroxy-3,5a,9-trimethylnaphtho[1,2-b]furan-2,6(3H,4H)-dione |
CHEMBL1422618
|
5 / 14 / 40 | No. 755 | No. 38 |
|
||
|
C00013088
|
[5aR-(5aalpha,6alpha,8alpha,9abeta,9balpha)]-8-(Acetyloxy)-5,5a,6,7,8,9,9a,9b-octahydro-6-hydroxy-3-(hydroxymethyl)-5a-methyl-9-methylenenaphtho[1,2-b]furan-2(4H)-one
|
No. 3757 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00003393 C00013072 | 7 / 37 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00003393 C00013072 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00003393 C00013072 | 0 / 0 |
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00003393 C00013072 | 7 / 3 |
| P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00003393 C00013072 | 0 / 0 |
| P39748 | Flap endonuclease 1 | Enzyme | C00006382 | 0 / 0 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00006382 | 1 / 1 |
| P06746 | DNA polymerase beta | Enzyme | C00006382 | 0 / 0 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00006382 | 0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00006382 | 0 / 0 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00006382 | 0 / 0 |
| Q9Y253 | DNA polymerase eta | Enzyme | C00006382 | 1 / 1 |
| OMIM | preferred title | UniProt |
|---|---|---|
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
| #202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
| #133239 | Esophageal cancer |
P04637
|
| #232300 | Glycogen storage disease ii |
P10253
|
| #151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
| #211980 | Lung cancer |
P04637
|
| #174800 | Mccune-albright syndrome; mas |
P63092
|
| #166350 | Osseous heteroplasia, progressive; poh |
P63092
|
| #260500 | Papilloma of choroid plexus; cpp |
P04637
|
| #102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
| #103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
| #603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
| #612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
| #275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
| #278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
| KEGG | name | UniProt |
|---|---|---|
| H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
| H00006 | Hairy-cell leukemia |
P04637
(related)
|
| H00008 | Burkitt lymphoma |
P04637
(related)
|
| H00009 | Adult T-cell leukemia |
P04637
(related)
|
| H00010 | Multiple myeloma |
P04637
(related)
|
| H00013 | Small cell lung cancer |
P04637
(related)
|
| H00014 | Non-small cell lung cancer |
P04637
(related)
|
| H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
| H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
| H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
| H00018 | Gastric cancer |
P04637
(related)
|
| H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
| H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
| H00022 | Bladder cancer |
P04637
(related)
|
| H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
| H00026 | Endometrial Cancer |
P04637
(related)
|
| H00027 | Ovarian cancer |
P04637
(related)
|
| H00028 | Choriocarcinoma |
P04637
(related)
|
| H00029 | Vulvar cancer |
P04637
(related)
|
| H00031 | Breast cancer |
P04637
(related)
|
| H00032 | Thyroid cancer |
P04637
(related)
|
| H00033 | Adrenal carcinoma |
P04637
(related)
|
| H00036 | Osteosarcoma |
P04637
(related)
|
| H00038 | Malignant melanoma |
P04637
(related)
|
| H00039 | Basal cell carcinoma |
P04637
(related)
|
| H00040 | Squamous cell carcinoma |
P04637
(related)
|
| H00041 | Kaposi's sarcoma |
P04637
(related)
|
| H00042 | Glioma |
P04637
(related)
P04637 (marker) |
| H00044 | Cancer of the anal canal |
P04637
(related)
|
| H00046 | Cholangiocarcinoma |
P04637
(related)
|
| H00047 | Gallbladder cancer |
P04637
(related)
|
| H00048 | Hepatocellular carcinoma |
P04637
(related)
|
| H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
| H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
| H01007 | Choroid plexus papilloma |
P04637
(related)
|
| H00021 | Renal cell carcinoma |
P04637
(marker)
|
| H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
| H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
| H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
| H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
| H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|